In various neurodegenerative diseases, including Alzheimer's disease (AD), PD, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, Hspb1 has been consistently observed to be upregulated, highlighting its significance as a key molecule of interest 42-46. This evidence concerns the gene HSPB1 and Parkinson disease.